The winner(s) will be honoured with a commemorative statuette and certificate and an invitation to the ECNP Congress.
The winner(s) may also be asked for an interview, to be published in ECNP communication channels.
Who is eligible?
Residents of European countries* who are affiliated with or have retired from a university, research institution or hospital, and whose research originates primarily in Europe.
Members of the ECNP Executive Committee, the chair of the ECNP Scientific Programme Committee and the members of the ECNP Award Committee are not eligible until three years after their term.
*The 46 countries of the Council of Europe, plus Israel.
How to nominate a candidate
The following documents are requested to be submitted:
- A short statement (one page), explaining the significance and impact of the nominee’s contribution to the field of the applied and translational neuroscience in Europe
- A summary curriculum vitae, including personal details, education and academic degrees, appointments, research experience, prizes, awards and honours, membership of professional organisations, editorial boards, publication lists, etc.
- Self-nominations are also welcome.
Selection of the winner(s)
The award winner(s) is selected by the ECNP Award Committee. Short-listed applicants may be asked to submit additional information before a final decision is taken.
The award cannot be shared and cannot be won more than once by the same individual. Nominees will be informed about the decision before 1 May 2026. There will be no correspondence about the outcome.
Award ceremony
The award will be presented at the 39th ECNP Congress 2026.
Previous winners
View the previous ECNP Lifetime Achievement Award winners.
| Year | Winners |
| 2025 | Kim Q. Do, Switzerland |
| 2024 | Jan van Ree, Netherlands Tomas Hökfelt, Sweden |
| 2023 | Aleksander Mathé, Sweden |
| 2012 | Jules Angst, Switzerland |
| 2010 | Moussa Youdim, Israel |
| 2018 | Jacques Glowinski, France |
| 2006 | Raphael Mechoulam, Israel |
Please note: this award was discontinued in 2012 and reestablished in 2023.